ZeOmega Funding: How Much Did They Raise & Key Investors

How Much Did ZeOmega Raise?
Funding & Key Investors

ZeOmega, a prominent player in the population health management sector, has successfully secured significant capital to bolster its enterprise-level operations. The firm has reached a cumulative milestone of $23.5M in total financing, reflecting its sustained growth trajectory within the healthcare technology landscape. This latest infusion of $2M serves as a major strategic investment, positioning the company to further refine its sophisticated software suite designed for complex health plan administration and clinical data integration.

The company's financial history demonstrates a clear evolution from its early-stage development to its current status as a mature enterprise solution provider. By securing diverse capital injections, including private equity and debt financing, ZeOmega has effectively scaled its infrastructure to meet the rigorous demands of Medicaid managed care plans, Medicare Advantage programs, and large-scale health systems.

What is ZeOmega?

ZeOmega

Software

Healthcare Software

Founded in 2001 and headquartered in Plano, Texas, ZeOmega provides comprehensive population health management solutions. The company specializes in enabling commercial health plans, ACOs, and managed care organizations to optimize clinical outcomes and operational efficiency. By leveraging advanced analytics and care management workflows, ZeOmega addresses the critical intersection of patient health data and administrative oversight, establishing itself as a vital partner for organizations navigating the complexities of modern value-based care models.

How much funding has ZeOmega raised?

ZeOmega has raised a total of $23.5M across 2 funding rounds:

2013

Private Equity

$21.5M

2020

Debt

$2M

Private Equity (2013): $21.5M with participation from Sandbox Industries, Bregal Sagemount, and BlueCross BlueShield Venture Partners

Debt (2020): $2M led by PPP

Key Investors in ZeOmega

Sandbox Industries

A venture capital firm focused on consumer technology, food, agriculture, and health care startups, providing strategic guidance to emerging enterprises.

Bregal Sagemount

A private equity and venture capital firm specializing in growth capital, middle-market financing, and later-stage strategic investments.

BlueCross BlueShield Venture Partners

A corporate venture fund managing over $500 million in capital, collaborating with Blue Cross and Blue Shield entities to invest in companies of strategic relevance to the healthcare industry.

What's next for ZeOmega?

With this recent strategic capital, ZeOmega is poised to accelerate its product roadmap and expand its market footprint. The focus will likely shift toward enhancing interoperability features and deepening the integration of its platform within the broader healthcare ecosystem. As the industry continues to prioritize data-driven decision-making, ZeOmega is well-positioned to leverage its robust financial backing to maintain its competitive edge, drive innovation in population health analytics, and support the evolving needs of its diverse client base across the United States.

See full ZeOmega company page

See More Financial Insights